Mumbai, India has emerged as a vital hub for the supply of Acalabrutinib Active Pharmaceutical Ingredient (API), with several companies focused on its synthesis . Notably, some manufacturers in this region are recognized for their high-quality Acalabrutinib (CAS 1420477-60-6) production, providing a